Ocular Toxocariasis

Emmett T Cunningham Jr^{1

2

3}, Manfred Zierhut⁴

Affiliations

¹ The Department of Ophthalmology, California Pacific Medical Center, San Francisco, California, USA.
² The Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA.
³ The Francis I. Proctor Foundation, UCSF School of Medicine, San Francisco, California, USA.
⁴ Centre for Ophthalmology, University Tuebingen, Tuebingen, Germany.

Editorial

Emmett T Cunningham Jr et al. Ocul Immunol Inflamm. 2021.

. 2021 Nov 17;29(7-8):1243-1245.

doi: 10.1080/09273948.2021.2018825.

Emmett T Cunningham Jr^{1

2

3}, Manfred Zierhut⁴

¹ The Department of Ophthalmology, California Pacific Medical Center, San Francisco, California, USA.
² The Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA.
³ The Francis I. Proctor Foundation, UCSF School of Medicine, San Francisco, California, USA.
⁴ Centre for Ophthalmology, University Tuebingen, Tuebingen, Germany.

No abstract available

Comment on

Pediatric Ocular Toxocariasis in Costa Rica: 1998-2018 Experience.
Martinez J, Ivankovich-Escoto G, Wu L. Martinez J, et al. Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1246-1251. doi: 10.1080/09273948.2020.1792513. Epub 2020 Aug 18. Ocul Immunol Inflamm. 2021. PMID: 32809906
Clinical Features and Prognostic Factors in Northern Chinese Patients with Peripheral Granuloma Type of Ocular Toxocariasis: A Retrospective Cohort Study.
Wang H, Tao Y. Wang H, et al. Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1259-1264. doi: 10.1080/09273948.2020.1804592. Epub 2020 Nov 13. Ocul Immunol Inflamm. 2021. PMID: 33185484
A Rare Case of Congenitally Acquired Ocular Toxocariasis in A Five-Week-Old Infant.
Or C, David JA, Singh M, Eustis HS, Mazzulla DA, Hypes S, Benevento J. Or C, et al. Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1277-1279. doi: 10.1080/09273948.2020.1866619. Epub 2021 Mar 4. Ocul Immunol Inflamm. 2021. PMID: 33661077
Keys to Unlock the Enigma of Ocular Toxocariasis: A Systematic Review and Meta-analysis.
Badri M, Eslahi AV, Olfatifar M, Dalvand S, Houshmand E, Abdoli A, Majidiani H, Eslami A, Zibaei M, Johkool MG, Taghipour A, Hashemipour S. Badri M, et al. Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1265-1276. doi: 10.1080/09273948.2021.1875007. Epub 2021 Apr 28. Ocul Immunol Inflamm. 2021. PMID: 33909531